Bristol Myers Squibb
- A07 - Antidiarreicos, antiinfecciosos y antiinflamatorios intestinales
- MYCOSTATIN oral suspension 100 000 IU/ml
- B01 - Agentes antitrombóticos
- ELIQUIS film-coated tablet 2.5 mg
- ELIQUIS film-coated tablet 5 mg
- PLAVIX film-coated tablet 300 mg
- PLAVIX film-coated tablet 75 mg
- C10 - Agentes modificadores de los lípidos
- QUESTRAN LOC powder for oral suspension 4 g
- H02 - Corticosteroides para uso sistémico
- FLORINEF tablet 0.1 mg
- J01 - Antibacterianos para uso sistémico
- DICLOCIL powder for solution for injection 1 g
- J05 - Antivirales de uso sistémico
- ATRIPLA film-coated tablet 200 mg+245 mg+600 mg
- BARACLUDE film-coated tablet 0.5 mg
- BARACLUDE film-coated tablet 1 mg
- BARACLUDE oral solution 0.05 mg/ml
- REYATAZ capsule, hard 150 mg
- REYATAZ capsule, hard 200 mg
- REYATAZ capsule, hard 300 mg
- L01 - Antineoplásicos
- SPRYCEL film-coated tablet 20 mg
- SPRYCEL film-coated tablet 50 mg
- SPRYCEL film-coated tablet 70 mg
- YERVOY concentrate for solution for infusion 200 mg/40 ml
- YERVOY concentrate for solution for infusion 50 mg/10 ml
- L04 - Inmunosupresores
- ORENCIA powder for solution for infusion 250 mg
- N02 - Analgésicos
- PERFALGAN solution for infusion 1 g/100 ml